Mandatory versus voluntary consent for newborn screening?
Creator
Ross, Lainie Friedman
Bibliographic Citation
Kennedy Institute of Ethics journal 2010 Dec; 20(4): 299-328
Abstract
Virtually every infant in the United States undergoes a heel stick within the first week of life to test for a variety of metabolic, endocrine, and hematological conditions as part of state-run universal newborn screening (NBS) programs. The history of this mandatory public health program is examined, as well as whether the policy was morally justifiable. Three changes in NBS practice necessitate a re-evaluation of the mandatory nature of NBS. First is the adoption of NBS for hemoglobinopathies in the 1980s that led to the identification of many sickle cell carriers and carriers of other hemoglobin variants. In all other contexts, carrier testing requires consent, and there is no moral rationale why NBS ought to be exceptional. Second is the application of tandem mass spectrometry (MS/MS) to NBS in the 1990s that led to the identification of many metabolic conditions and variants, some of which were not treatable and others of which had unknown clinical relevance. To the extent that the conditions do not need emergent diagnosis and treatment, there is less justification for mandatory screening. Third, there is great interest in using residual blood spots for research, and the cornerstone of research ethics is the voluntary consent of the participant (or his or her proxy). These three changes support revising mandatory NBS with a tiered consent process to best balance respect for parental autonomy and the promotion of children's health.
Permanent Link
http://hdl.handle.net/10822/515984Date
2010-12Subject
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Newborn screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy
Ross, Lainie Friedman (2009)